Source: Υπουργείο Υγείας (CY) Revision Year: 2020 Publisher: Remedica Ltd, Aharnon Str., Limassol Industrial Estate, 3056 Limassol, Cyprus
Ozapram 5 mg film-coated tablets.
Ozapram 10 mg film-coated tablets.
Ozapram 20 mg film-coated tablets.
Pharmaceutical Form |
---|
Film-coated tablet. Ozapram 5 mg film-coated tablets : White to off white, round, film-coated tablets. Ozapram 10 mg film-coated tablets : White to off white, round, film-coated tablets. Ozapram 20 mg film-coated tablets: White to off white, oval, film-coated tablets. |
Ozapram 5 mg film-coated tablets:
Each film-coated tablet contains 5 mg olanzapine.
Ozapram 10 mg film-coated tablets:
Each film-coated tablet contains 10 mg olanzapine.
Ozapram 20 mg film-coated tablets:
Each film-coated tablet contains 20 mg olanzapine.
Ozapram 5 mg film-coated tablets: This product contains 108.347 mg lactose.
Ozapram 10 mg film-coated tablets: This product contains 216.694 mg lactose.
Ozapram 20 mg film-coated tablets: This product contains 433.388 mg lactose.
For the full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Olanzapine |
Olanzapine is an antipsychotic, antimanic and mood stabilising agent that demonstrates a broad pharmacologic profile across a number of receptor systems. |
List of Excipients |
---|
Core: Lactose monohydrate Coating: Hypromellose |
Aluminium/Aluminium blisters. Pack-sizes of 28 and 30 film-coated tablets.
Not all pack sizes may be marketed.
Remedica Ltd, Aharnon Str., Limassol Industrial Estate, 3056 Limassol, Cyprus
Ozapram 5 mg film-coated tablets: 21833
Ozapram 10 mg film-coated tablets: 21835
Ozapram 20 mg film-coated tablets: 21837
Date of first authorisation: 19 July 2013
Date of latest renewal: 10 May 2019
Drug | Countries | |
---|---|---|
OZAPRAM | Cyprus, Malta |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.